The Platform Group reported a robust first quarter in late May, with gross merchandise volume climbing 23% year-on-year to €438.4 million and adjusted EBITDA rising to €21.8 million. But the market’s response has been anything but rational. In a single session on Monday, the stock plunged as much as 42% intraday, touching €1.30 on Xetra before recovering to around €1.50. The slide accelerated further, with the shares later changing hands at €1.34 — a level that now sits 76% below the February all-time high of €5.60.
No corporate announcement triggered the collapse. There was no profit warning, no ad-hoc disclosure. The suddenness has drawn attention to a pair of knock‑out call warrants that expired on Tuesday, 16 June — one with a strike of €2.00 and a leverage of 14.06, the other at €1.60 with a leverage of 11.47. Both were listed on Lang & Schwarz with an unusually tight bid‑ask spread of €0.006 to €0.026. Whether these derivatives amplified the selling or merely reflected it cannot be determined from available data, but their presence added a layer of mechanical pressure to an already nervous market.
Amid the turmoil, a board member stepped in. Dr. Dominik Pasqual Benner acquired 10,130 shares on 12 June at €1.88 apiece, for a total of just over €19,051. The transaction was executed off-exchange and flagged as a directors’ dealings. Yet the vote of confidence has so far fallen flat. The current price of €1.34 represents a 29% discount to Benner’s purchase price, and the stock dropped another 4.61% on the day the buy was reported. The seven‑day loss now stands at almost 43%, while the 30‑day decline has reached roughly 58%.
Should investors sell immediately? Or is it worth buying The Platform Group?
The technical picture is extreme. The relative strength index sits at 21.5, deep in oversold territory, and the annualised 30‑day volatility has surged to 137%. On Monday the stock also carved out a fresh 52‑week low of €1.20, a long way from the 52‑week high of €11.00 — a number that underscores how far the shares have fallen over a broader time frame.
Behind the price collapse lies persistent concern about the balance sheet. In its Q1 report on 27 May, the company disclosed a leverage ratio of 2.1x for 2025 and outlined a plan to reduce it to between 1.0x and 1.4x by 2030. The tools cited are long‑term bank loans, equity, bonds and active working‑capital management. Management reaffirmed its full‑year guidance: a gross merchandise volume of €1.7 billion, net revenue of €1.0 billion, and adjusted EBITDA in a range of €70 million to €80 million. Those numbers now sit against a stock price that has halved since the report was published.
The coming weeks offer several opportunities for the group to address the market’s doubts. On 25 June, The Platform Group will attend the Portzamparc BNP Paribas Mid & Small Caps Conference in Paris. That will be followed by the annual general meeting in Düsseldorf on 1 July, where the board is expected to defend its financing strategy and may face pointed questions about debt reduction. The half‑year results are scheduled for 20 August. For now, the insider purchase adds a data point alongside the operational communication — but it has done little to stem the selling or shift the narrative around liquidity and confidence.
Ad
The Platform Group Stock: Buy or Sell?! New The Platform Group Analysis from June 16 delivers the answer:
The latest The Platform Group figures speak for themselves: Urgent action needed for The Platform Group investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 16.
The Platform Group: Buy or sell? Read more here...










